Evidence for Nucleoside Diphosphokinase-dependent Channeling of Guanosine 5'-(gamma-thio)triphosphate to Guanine Nucleotide-binding Proteins
Overview
Pharmacology
Authors
Affiliations
Agonist binding to guanine nucleotide-binding protein (G protein)-coupled receptors in membranes of myeloid differentiated human leukemia (HL-60) cells is inhibited by guanine nucleotides, most potently by the GTP analog guanosine 5'-(gamma-thio)triphosphate (GTP gamma S). In order to study whether GTP gamma S formed locally from adenosine 5'-(gamma-thio)triphosphate (ATP gamma S) and GDP by nucleoside diphosphokinase has any advantage over exogenously added GTP gamma S in binding to and activating G proteins, regulation of complement component 5a (C5a) binding to its receptors, as well as formation of GTP gamma S, was studied in membranes of HL-60 cells. GTP gamma S added to HL-60 membranes potently inhibited binding of 125I-C5a (IC50 about 3 nM), an effect not influenced by addition of either GDP or ATP gamma S. When HL-60 membranes were incubated with the combination of ATP gamma S and GDP, a marked potentiation (up to 300-fold) of the inhibition caused by either GDP or ATP gamma S alone was observed. By measuring nucleoside diphosphokinase-catalyzed formation of GTP gamma S and inhibition of 125I-C5a binding in the presence of GDP and ATP gamma S under identical assay conditions, it was found that formed GTP gamma S inhibited binding of 125I-C5a with an IC50 value of about 0.3 nM, thus being about 10-fold more potent than exogenously added GTP gamma S. These data suggest that the GTP gamma S-forming nucleoside diphosphokinase is closely associated with the C5a receptor-G protein complex and channels the formed GTP gamma S into the G protein.
PRUNE1 and NME/NDPK family proteins influence energy metabolism and signaling in cancer metastases.
Ferrucci V, Lomada S, Wieland T, Zollo M Cancer Metastasis Rev. 2024; 43(2):755-775.
PMID: 38180572 PMC: 11156750. DOI: 10.1007/s10555-023-10165-4.
Aktories K, Gierschik P, Heringdorf D, Schmidt M, Schultz G, Wieland T Naunyn Schmiedebergs Arch Pharmacol. 2019; 392(8):887-911.
PMID: 31101932 DOI: 10.1007/s00210-019-01650-1.
Regulation of heterotrimeric G-protein signaling by NDPK/NME proteins and caveolins: an update.
Abu-Taha I, Heijman J, Feng Y, Vettel C, Dobrev D, Wieland T Lab Invest. 2017; 98(2):190-197.
PMID: 29035382 DOI: 10.1038/labinvest.2017.103.
Wieland T Naunyn Schmiedebergs Arch Pharmacol. 2007; 374(5-6):373-83.
PMID: 17200862 DOI: 10.1007/s00210-006-0126-6.
Hippe H, Wieland T J Bioenerg Biomembr. 2006; 38(3-4):197-203.
PMID: 16957986 DOI: 10.1007/s10863-006-9035-0.